Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""VASCULAR endothelial growth factors"" wg kryterium: Temat


Tytuł :
Flow signal change in polyps after anti-vascular endothelial growth factor therapy.
Autorzy :
Chang CJ; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan.
Huang YM; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan.
Hsieh MH; Hoping Branch, Taipei City Hospital, Taipei, Taiwan.
Li AF; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan.; National Yang-Ming University School of Medicine, Taipei, Taiwan.; Department of Ophthalmology, Cheng Hsin General Hospital, Taipei, Taiwan.
Chen SJ; Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan.; National Yang-Ming University School of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Oct 23; Vol. 15 (10), pp. e0241230. Date of Electronic Publication: 2020 Oct 23 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Regional Blood Flow*/drug effects
Signal Processing, Computer-Assisted*
Polyps/*drug therapy
Vascular Endothelial Growth Factors/*antagonists & inhibitors
Aged ; Aged, 80 and over ; Choroidal Neovascularization/diagnostic imaging ; Choroidal Neovascularization/drug therapy ; Female ; Fluorescein Angiography ; Humans ; Indocyanine Green ; Intravitreal Injections ; Male ; Middle Aged ; Polyps/diagnostic imaging ; Receptors, Vascular Endothelial Growth Factor/administration & dosage ; Receptors, Vascular Endothelial Growth Factor/therapeutic use ; Recombinant Fusion Proteins/administration & dosage ; Recombinant Fusion Proteins/pharmacology ; Recombinant Fusion Proteins/therapeutic use ; Tomography, Optical Coherence ; Treatment Outcome ; Vascular Endothelial Growth Factors/metabolism
Czasopismo naukowe
Tytuł :
Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer.
Autorzy :
Somasundaram A; Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Socinski MA; Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Advent Health Cancer Institute, Orlando, FL, USA.
Villaruz LC; Division of Hematology/Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. .
Pokaż więcej
Źródło :
Drugs [Drugs] 2020 Jun; Vol. 80 (9), pp. 883-892.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents/*pharmacology
Carcinoma, Non-Small-Cell Lung/*drug therapy
Immune Checkpoint Inhibitors/*therapeutic use
Lung Neoplasms/*drug therapy
Protein Kinase Inhibitors/*pharmacology
Vascular Endothelial Growth Factors/*antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/metabolism ; Humans ; Lung Neoplasms/immunology ; Lung Neoplasms/metabolism ; Vascular Endothelial Growth Factors/metabolism
Czasopismo naukowe
Tytuł :
Expression of HIF-1α and VEGF in feline mammary gland carcinomas: association with pathological characteristics and clinical outcomes.
Autorzy :
Chen B; Graduate Institute of Molecular and Comparative Pathobiology, National Taiwan University, Taipei, Taiwan.
Lin SJ; Graduate Institute of Molecular and Comparative Pathobiology, National Taiwan University, Taipei, Taiwan.
Li WT; Graduate Institute of Molecular and Comparative Pathobiology, National Taiwan University, Taipei, Taiwan.
Chang HW; Graduate Institute of Molecular and Comparative Pathobiology, National Taiwan University, Taipei, Taiwan.
Pang VF; Graduate Institute of Molecular and Comparative Pathobiology, National Taiwan University, Taipei, Taiwan.
Chu PY; Department of Pathology, Show Chwan Memorial Hospital, Changhua, Taiwan.
Lee CC; Department of Pathology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Nakayama H; Department of Pathology, The University of Tokyo, Tokyo, Japan.
Wu CH; Institute of Veterinary Clinical Science, School of Veterinary Medicine, National Taiwan University, Taipei, Taiwan. .
Jeng CR; Graduate Institute of Molecular and Comparative Pathobiology, National Taiwan University, Taipei, Taiwan. .
Pokaż więcej
Źródło :
BMC veterinary research [BMC Vet Res] 2020 May 06; Vol. 16 (1), pp. 125. Date of Electronic Publication: 2020 May 06.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinoma/*veterinary
Hypoxia-Inducible Factor 1, alpha Subunit/*genetics
Mammary Neoplasms, Animal/*genetics
Vascular Endothelial Growth Factors/*genetics
Animals ; Carcinoma/genetics ; Carcinoma/mortality ; Carcinoma/pathology ; Cat Diseases/genetics ; Cat Diseases/mortality ; Cat Diseases/pathology ; Cats ; Female ; Gene Expression Regulation, Neoplastic ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Male ; Mammary Neoplasms, Animal/mortality ; Mammary Neoplasms, Animal/pathology ; Prognosis ; Retrospective Studies ; Vascular Endothelial Growth Factors/metabolism
Czasopismo naukowe
Tytuł :
Changes in inner retinal layer thickness in patients with exudative age-related macular degeneration during treatment with anti-vascular endothelial growth factor.
Autorzy :
Lee SW; Department of Ophthalmology, Sanggye Paik Hospital, Inje University, Seoul.
Sim HE; Department of Ophthalmology, Sanggye Paik Hospital, Inje University, Seoul.
Park JY; Department of Ophthalmology, Sanggye Paik Hospital, Inje University, Seoul.
Kim JS; Department of Ophthalmology, Sanggye Paik Hospital, Inje University, Seoul.
Chang IB; Department of Ophthalmology, Busan Paik Hospital, Inje University, Busan.
Park YS; Eye love eye Clinic, Seoul, South Korea.
Hwang JH; Department of Ophthalmology, Sanggye Paik Hospital, Inje University, Seoul.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Apr; Vol. 99 (17), pp. e19955.
Typ publikacji :
Journal Article
MeSH Terms :
Weights and Measures*
Macular Degeneration/*drug therapy
Retina/*pathology
Vascular Endothelial Growth Factors/*therapeutic use
Aged ; Aged, 80 and over ; Angiogenesis Inhibitors/pharmacology ; Angiogenesis Inhibitors/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Ranibizumab/pharmacology ; Ranibizumab/therapeutic use ; Receptors, Vascular Endothelial Growth Factor/therapeutic use ; Recombinant Fusion Proteins/pharmacology ; Recombinant Fusion Proteins/therapeutic use ; Retina/physiopathology ; Retrospective Studies ; Statistics, Nonparametric ; Vascular Endothelial Growth Factors/pharmacology
Czasopismo naukowe
Tytuł :
基于网络药理学研究桃红四物汤治疗假体周围感染的潜在靶点和机制.
Autorzy :
袁家威
张海涛
揭 珂
曹厚然
曾意荣
Pokaż więcej
Alternatywny tytuł :
Underlying targets and mechanism of Taohong Siwu Decoction in prosthetic joint infection on network pharmacology.
Źródło :
Chinese Journal of Tissue Engineering Research / Zhongguo zu zhi gong cheng yan jiu. 3/28/2021, Vol. 25 Issue 9, p1428-1433. 6p.
Czasopismo naukowe
Tytuł :
miR-17-5p 调控低氧诱导因子1α 介导脂肪细胞分化及血管生成的分子机制.
Autorzy :
刘 聪
刘 肃
Pokaż więcej
Alternatywny tytuł :
Molecular mechanism of miR-17-5p regulation of hypoxia inducible factor-1α mediated adipocyte differentiation and angiogenesis.
Źródło :
Chinese Journal of Tissue Engineering Research / Zhongguo zu zhi gong cheng yan jiu. 3/8/2021, Vol. 25 Issue 7, p1069-1074. 6p.
Czasopismo naukowe
Tytuł :
缺氧预处理激活 HIF-1α/MALAT1/VEGFA 通路促进骨髓间充质干细胞生存和 血管再生.
Autorzy :
侯婧瑛
于萌蕾
郭天柱
龙会宝
吴 浩
Pokaż więcej
Alternatywny tytuł :
Hypoxia preconditioning promotes bone marrow mesenchymal stem cells survival and vascularization through the activation of HIF-1α/MALAT1/VEGFA pathway.
Źródło :
Chinese Journal of Tissue Engineering Research / Zhongguo zu zhi gong cheng yan jiu. 3/8/2021, Vol. 25 Issue 7, p985-990. 6p.
Czasopismo naukowe
Tytuł :
Postponing tumor onset and tumor progression can be achieved by alteration of local tumor immunity.
Autorzy :
Mei, Yan (AUTHOR)
Wang, Mingdian (AUTHOR)
Lu, Guanming (AUTHOR)
Li, Jiangchao (AUTHOR)
Peng, Lixia (AUTHOR)
Lang, Yanhong (AUTHOR)
Yang, Mingming (AUTHOR)
Jiang, Lingbi (AUTHOR)
Li, Changzhi (AUTHOR)
Zheng, Lisheng (AUTHOR)
Liu, Zhijie (AUTHOR)
Xie, Dehuan (AUTHOR)
Guo, Lingling (AUTHOR)
Huang, Bijun (AUTHOR)
Zeng, Musheng (AUTHOR)
Shi, Yanxia (AUTHOR)
Qian, Chaonan (AUTHOR)
Pokaż więcej
Źródło :
Cancer Cell International. 2/10/2021, Vol. 21 Issue 1, p1-12. 12p.
Czasopismo naukowe
Tytuł :
Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW.
Autorzy :
Huisman, Lydian A.
Steinkamp, Pieter J.
Hillebrands, Jan-Luuk
Zeebregts, Clark J.
Linssen, Matthijs D.
Jorritsma-Smit, Annelies
Slart, Riemer H. J. A.
van Dam, Gooitzen M.
Boersma, Hendrikus H.
Pokaż więcej
Źródło :
Scientific Reports. 2/3/2021, Vol. 11 Issue 1, p1-11. 11p.
Czasopismo naukowe
Tytuł :
Effect of Decorin and Bevacizumab on oxygen-induced retinopathy in rat models: A comparative study.
Autorzy :
Duran Güler, Seda (AUTHOR)
Balbaba, Mehmet (AUTHOR)
Çolakoğlu, Neriman (AUTHOR)
Bulmuş, Özgür (AUTHOR)
Ulaş, Fatih (AUTHOR)
Eröksüz, Yesari (AUTHOR)
Duran G Ler, Seda (AUTHOR)
Bulmuş, Özgör (AUTHOR)
Pokaż więcej
Źródło :
Indian Journal of Ophthalmology. Feb2021, Vol. 69 Issue 2, p369-373. 5p.
Czasopismo naukowe
Tytuł :
Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1.
Autorzy :
Wang, Qiong (AUTHOR)
Wang, Guanwen (AUTHOR)
Niu, Lianjie (AUTHOR)
Zhao, Shaorong (AUTHOR)
Li, Jianjun (AUTHOR)
Zhang, Zhen (AUTHOR)
Jiang, Huimin (AUTHOR)
Zhang, Quansheng (AUTHOR)
Wang, Hang (AUTHOR)
Sun, Peiqing (AUTHOR)
Xiang, Rong (AUTHOR)
Chang, Antao (AUTHOR)
Yang, Shuang (AUTHOR)
Pokaż więcej
Źródło :
Journal of Oncology. 1/29/2021, p1-13. 13p.
Czasopismo naukowe
Tytuł :
Yangxue Jiedu Fang Ameliorates Psoriasis by Regulating Vascular Regression via Survivin/PI3K/Akt Pathway.
Autorzy :
Lv, Hongpeng (AUTHOR)
Liu, Xin (AUTHOR)
Chen, Weiwen (AUTHOR)
Xiao, Shiju (AUTHOR)
Ji, Yunrun (AUTHOR)
Han, Xuyang (AUTHOR)
Li, Yafan (AUTHOR)
Wang, Xiaoxu (AUTHOR)
Zhang, Guangzhong (AUTHOR)
Li, Ping (AUTHOR)
Pokaż więcej
Źródło :
Journal of Immunology Research. 1/18/2021, p1-18. 18p. 1 Color Photograph, 1 Black and White Photograph, 11 Graphs.
Czasopismo naukowe
Tytuł :
Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy.
Autorzy :
Osumi, Hiroki (AUTHOR)
Shinozaki, Eiji (AUTHOR)
Ooki, Akira (AUTHOR)
Wakatsuki, Takeru (AUTHOR)
Kamiimabeppu, Daisaku (AUTHOR)
Sato, Taro (AUTHOR)
Nakayama, Izuma (AUTHOR)
Ogura, Mariko (AUTHOR)
Takahari, Daisuke (AUTHOR)
Chin, Keisho (AUTHOR)
Yamaguchi, Kensei (AUTHOR)
Pokaż więcej
Źródło :
Cancer Medicine. Jan2021, Vol. 10 Issue 2, p615-625. 11p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies